Percutaneous vascular stent implantation as treatment for central vascular obstruction due to fibrosing mediastinitis

Circulation

Volumn 123, Issue 13, 2011, Pages 1391-1399

  Albers, Erin L ^a,d   Pugh, Meredith E ^b   Hill, Kevin D ^a,c   Wang, Li ^b   Loyd, James E ^b   Doyle, Thomas P ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine ^*  (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

fibrosing mediastinitis; pulmonary heart disease; stenosis; stents

Indexed keywords

ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CLINICAL FEATURE; FEMALE; FIBROSING MEDIASTINITIS; FOLLOW UP; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; MORTALITY; PRESSURE GRADIENT; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY VEIN; RECURRENCE RISK; RETROSPECTIVE STUDY; STENT; SUPERIOR CAVA VEIN; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; FEMALE; FIBROSIS; HEART CATHETERIZATION; HUMANS; MALE; MEDIASTINITIS; MIDDLE AGED; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 79954633399     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.949180     Document Type: Article

References (32)

1. Goodwin RA, Loyd JE, Des Prez RM. Histoplasmosis in normal hosts. Medicine (Baltimore). 1981;60:231-266. (Pubitemid 11079842)
2. Davis AM, Pierson RN, Loyd JE. Mediastinal fibrosis. Semin Respir Infect. 2001;16:119-130. (Pubitemid 32606849)
3. Loyd JE, Tillman BF, Atkinson JB, Des Prez RM. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore). 1988;67:295-310.
4. Goodwin RA, Nickell JA, Des Prez RM. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore). 1972;51:227-246.
5. Berry DF, Buccigrossi D, Peabody J, Peterson KL, Moser KM. Pulmonary vascular occlusion and fibrosing mediastinitis. Chest. 1986;89: 296-301. (Pubitemid 16156436)
6. Martin J, Prudhomme J, Scott T, Loyd J. Features associated with mortality in fibrosing mediastinits. Am J Respir Crit Care Med. 2005;2:A204. Abstract.
7. Mathisen DJ, Grillo HC. Clinical manifestation of mediastinal fibrosis and histoplasmosis. Ann Thorac Surg. 1992;54:1053-1057; discussion 1057-1058.
8. Maholtz MS, Dauber JH, Yousem SA. Case report: fluconazole therapy in histoplasma mediastinal granuloma. Am J Med Sci. 1994;307:274-277. (Pubitemid 24109152)
9. Mocherla S, Wheat LJ. Treatment of histoplasmosis. Semin Respir Infect. 2001;16:141-148. (Pubitemid 32606851)
10. Wheat LJ, Conces D, Allen SD, Blue-Hnidy D, Loyd J. Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management. Semin Respir Crit Care Med. 2004;25:129-144. (Pubitemid 38544247)
11. Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, Kauffman CA. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807-825. (Pubitemid 47580372)
12. Garrett HE Jr, Roper CL. Surgical intervention in histoplasmosis. Ann Thorac Surg. 1986;42:711-722. (Pubitemid 17195043)
13. Shaffer KM, Mullins CE, Grifka RG, O'Laughlin MP, McMahon W, Ing FF, Nihill MR. Intravascular stents in congenital heart disease: short-and long-term results from a large single-center experience. J Am Coll Cardiol. 1998;31:661-667. (Pubitemid 28144135)
14. O'Laughlin MP, Slack MC, Grifka RG, Perry SB, Lock JE, Mullins CE. Implantation and intermediate-term follow-up of stents in congenital heart disease. Circulation. 1993;88:605-614. (Pubitemid 23228061)
15. O'Laughlin MP, Perry SB, Lock JE, Mullins CE. Use of endovascular stents in congenital heart disease. Circulation. 1991;83:1923-1939.
16. Dodds GA III, Harrison JK, O'Laughlin MP, Wilson JS, Kisslo KB, Bashore TM. Relief of superior vena cava syndrome due to fibrosing mediastinitis using the Palmaz stent. Chest. 1994;106:315-318. (Pubitemid 24214785)
17. Doyle TP, Loyd JE, Robbins IM. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Am J Respir Crit Care Med. 2001;164:657-660. (Pubitemid 32801673)
18. Fontaine AB, Borsa JJ, Hoffer EK, Bloch RD, So C. Stent placement in the treatment of pulmonary artery stenosis secondary to fibrosing mediastinitis. J Vasc Interv Radiol. 2001;12:1107-1111. (Pubitemid 32844861)
19. Guerrero A, Hoffer EK, Hudson L, Schuler P, Karmy-Jones R. Treatment of pulmonary artery compression due to fibrous mediastinitis with endovascular stent placement. Chest. 2001;119:966-968. (Pubitemid 32197675)
20. Kandzari DE, Warner JJ, O'Laughlin MP, Harrison JK. Percutaneous stenting of right pulmonary artery stenosis in fibrosing mediastinitis. Catheter Cardiovasc Interv. 2000;49:321-324. (Pubitemid 30133526)
21. Recto MR, Bousamra M, Yeh T Jr. Late superior vena cava perforation and aortic laceration after stenting to treat superior vena cava syndrome secondary to fibrosing mediastinitis. J Invasive Cardiol. 2002;14: 624-629. (Pubitemid 35178261)
22. Satpathy R, Aguila V, Mohiuddin SM, Khan IA. Fibrosing mediastinitis presenting as pulmonary stenosis: stenting works. Int J Cardiol. 2007; 118:e85-e86. (Pubitemid 46678260)
23. Thomas BP, Bream PR Jr, Milstone AP, Meranze SG. Treatment of SVC syndrome and hemoptysis in a patient with mediastinal fibrosis. Emerg Radiol. 2006;12:240-243. (Pubitemid 44065559)
24. Ganeshan A, Hon LQ, Warakaulle DR, Morgan R, Uberoi R. Superior vena caval stenting for SVC obstruction: current status. Eur J Radiol. 2009;71:343-349.
25. Rizvi AZ, Kalra M, Bjarnason H, Bower TC, Schleck C, Gloviczki P. Benign superior vena cava syndrome: stenting is now the first line of treatment. J Vasc Surg. 2008;47:372-380. (Pubitemid 351172658)
26. Sheikh MA, Fernandez BB Jr, Gray BH, Graham LM, Carman TL. Endovascular stenting of nonmalignant superior vena cava syndrome. Catheter Cardiovasc Interv. 2005;65:405-411. (Pubitemid 40898185)
27. Urruticoechea A, Mesia R, Dominguez J, Falo C, Escalante E, Montes A, Sancho C, Cardenal F, Majem M, Germa JR. Treatment of malignant superior vena cava syndrome by endovascular stent insertion: experience on 52 patients with lung cancer. Lung Cancer. 2004;43:209-214. (Pubitemid 38114750)
28. Law MA, Shamszad P, Nugent AW, Justino H, Breinholt JP, Mullins CE, Ing FF. Pulmonary artery stents: long-term follow-up. Catheter Cardiovasc Interv. 2010;75:757-764.
29. Stanfill R, Nykanen DG, Osorio S, Whalen R, Burke RP, Zahn EM. Stent implantation is effective treatment of vascular stenosis in young infants with congenital heart disease: acute implantation and long-term follow-up results. Catheter Cardiovasc Interv. 2008;71:831-841. (Pubitemid 351656336)
30. Neumann T, Kuniss M, Conradi G, Sperzel J, Berkowitsch A, Zaltsberg S, Wojcik M, Erkapic D, Dill T, Hamm CW, Pitschner HF. Pulmonary vein stenting for the treatment of acquired severe pulmonary vein stenosis after pulmonary vein isolation: clinical implications after long-term follow-up of 4 years. J Cardiovasc Electrophysiol. 2009;20:251-257.
31. Sreeram N, Emmel M, Trieschmann U, Brockmeier K, Bennink G. Pulmonary vein stents in infants and children: is there lasting benefit? Clin Res Cardiol. 2008;97:463-466.
32. Brown ML, Cedeno AR, Edell ES, Hagler DJ, Schaff HV. Operative strategies for pulmonary artery occlusion secondary to mediastinal fibrosis. Ann Thorac Surg. 2009;88:233-237.